Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Neste Corporation's disposal of own shares based on the share ownership plan

Neste Corporation, Stock Exchange Release, 15 March 2022 at 5 p.m. (EET) A total of 113,774 treasury shares of Neste Corporation has on 15 March 2022 been conveyed without consideration to the key persons participating in the Performance Share Plan 2019-2021 and in the Restricted Share Plan 2019-2021 of the share-based incentive program 2019 in accordance with the terms and conditions of the program. The decision of the Board of Directors on the share transfer is based on a share issue authorization granted by the Annual General Meeting of Shareholders on 18 May 2020. A total of 90

Holding(s) in Company

TR-1: Standard form for notification of major holdings [][][][][][][]NOTIFICATION OFMAJOR HOLDINGS(to besent to the relevantissuer and tothe FCA in MicrosoftWord format ifpossible)[i] 1a. Identity of the EnQuest PLCissuer or theunderlying issuer ofexisting sharesto which votingrights areattached[ii]:1b. Please indicateif the issuer isa non-UK issuer (please mark withan "X" ifappropriate)Non-UK issuer2. Reason for thenotification (pleasemark theappropriate box orboxes with an"X")An acquisition or

Correction MAR label - Prostatype Genomics establishes subsidiary in the United States

The correction refers to the MAR label. This press release should be without the MAR label.Prostatype Genomics is now establishing a subsidiary in the USA, Prostatype Genomics, Inc., wholly owned 100% by Prostatype Genomics AB. It is an important step in the work towards the American market entry.Prostate cancer is today the second most common form of cancer among American men, and in 2022 it is estimated that almost 270,000 American men will be diagnosed with prostate cancer. A rapid establishment in the American market, together with commercial establishment in Europe, are Prostatype

Momentum Group publishes prospectus

Alligo AB (publ)’s (“Alligo”) subsidiary Momentum Group AB (publ) (“Momentum Group”) has today published the prospectus prepared ahead of the admission to trading of Momentum Group’s Class B shares on Nasdaq Stockholm.On 25 February 2022, Alligo announced that the Board of Directors had decided to propose that the shareholders of Alligo at the Extraordinary General Meeting on 23 March 2022 resolve to distribute all of Alligo's shares in Momentum Group to Alligo's shareholders and that Momentum Group's Class B shares are to be listed on Nasdaq Stockholm. In connection with the planned

Hansa Biopharma and German payer head association agree on reimbursement price for Idefirix[®] (imlifidase) as desensitization treatment for highly sensitized kidney transplant patients

· Hansa Biopharma completes the AMNOG reimbursement process for Idefirix[®] in Germany · Hansa and National Association of Statutory Health Insurance Funds (GKV-SV) agree on reimbursement price · German hospitals can receive extra funding for the final reimbursement price based on a positive NUB status 1 decision Lund, Sweden, March 15, 2022. Hansa Biopharma AB, “Hansa” (Nasdaq Stockholm: HNSA), the pioneer in enzyme technology for rare immunological conditions, today announces having reached an agreement on the reimbursement for Idefirix in Germany with the National Association of

Notice of Annual General Meeting 2022

(Corrected version) The annual general meeting of Aker BP ASA will be held on Tuesday 5 April 2022 at 09:00 CEST. The general meeting will be held as a digital meeting only, with no physical attendance for shareholders. Voting will be handled online during the meeting. Information about log-in details for the meeting is available in the notice of the general meeting. A guide for online participation is available on https://akerbp.com/general-meeting/. Please find attached the following documents: · Aker BP - Notice of Annual General Meeting 2022 - corrected.pdf 

Teleste´s Annual Report 2021 published

TELESTE CORPORATION  STOCK EXCHANGE RELEASE  15.3.2022 AT 16:00 EET TELESTE´S ANNUAL REPORT 2021 PUBLISHED   Teleste Corporation’s Annual Report 2021 and Financial Statements for the accounting period 1 January – 31 December 2021 and the Remuneration report have been published today in English and in Finnish on the company’s website at teleste.com/financial-reports   The Annual Report includes Board of Directors’ Report, Financial Statements and Auditors’ Report. Teleste has also published its Corporate Governance Statement 2021 separately from the Board of Directors’

Toivo Group Oyj - Managers' Transactions - Asko Myllymäki

Toivo Group Oyj - Managers' Transactions - 15 March 2022 at 4 p.m. ____________________________________________ Person subject to the notification requirement Name: Sirkka Myllymäki Position: Closely associated person (1):Person Discharging Managerial Responsibilities In Issuer Name: Asko Myllymäki Position: Member of the Board Issuer: Toivo Group Oyj LEI: 743700N31WYJDNPT8M98 Notification type: INITIAL NOTIFICATION Reference number: 11413/5/4 ____________________________________________ Transaction date: 2022-03-14 Venue: FIRST NORTH GROWTH MARKET

Norse Atlantic Airways secures London Gatwick slots and adapts launch plans

The current market situation is heavily impacted by the tragic events unfolding in Ukraine that have resulted in increased fuel prices and uncertainties relating to travel demand. To ensure that the Company enters the market at the right time, Norse has adjusted its launch of ticket sales and initial route offering; the company plans ticket sales to commence in April and first flight is expected to be in June 2022. At the same time, the Company has secured important slots at London Gatwick Airport.“The tragedy unfolding in Ukraine creates uncertainties within international air transport

Proposal from the Betsson’s Nomination Committee

For the Annual General Meeting 2022, re-election of Board members Johan Lundberg, Eva Leach, Pontus Lindwall and Peter Hamberg and new election of Eva de Falck, Louise Nylén and Tristan Sjöberg is proposed. Fredrik Carlsson has declined re-election. Johan Lundberg is proposed to be elected Chairman of the Board.Active ownership responsibility via board position There is a positive view in both Swedish society and among institutional investors that major shareholders are to take special responsibility by actively participating in the management of listed companies through a position on

Stora Enso’s Annual General Meeting and decisions by the Board of Directors

STORA ENSO OYJ STOCK EXCHANGE RELEASE 15 March 2022 at 15:45 EETStora Enso Oyj’s (Company) Annual General Meeting (AGM) was held on 15 March 2022 at the Company's Head Office in Helsinki, Finland. In order to prevent the spread of the Covid-19 pandemic, a shareholder or his/her proxy representative could not be present at the venue of the meeting. A total of 2 324 shareholders representing approximately 541 million shares and 199 million votes were represented at the meeting. The AGM supported all the proposals made by the Shareholders’ Nomination Board and the Board of Directors to the AGM

The subscription price for the exercise of warrants has been determined

The subscription price for subscription of new ordinary shares with series 4 (TO4) warrants in Quartiers Properties AB (publ) (“Quartiers” or the “Company”) has been set to SEK 3.71 per ordinary share.In total, there are 3,291,624 TO4 series 2020/2022 warrants. One (1) warrant entitles the holder to subscribe for one (1) new ordinary share in the Company during the period from 17 March 2022 to 31 March 2022. If fully exercised, the Company could receive approximately SEK 12 million.

Prostatype Genomics establishes subsidiary in the United States

Prostatype Genomics is now establishing a subsidiary in the USA, Prostatype Genomics, Inc., wholly owned 100% by Prostatype Genomics AB. It is an important step in the work towards the American market entry.Prostate cancer is today the second most common form of cancer among American men, and in 2022 it is estimated that almost 270,000 American men will be diagnosed with prostate cancer. A rapid establishment in the American market, together with commercial establishment in Europe, are Prostatype Genomics' focus areas. Fast and efficient road to market entryThe company's genetic test

ExpreS2ion publishes video from company presentation at Aktiespararna’s Aktiedagen

Hørsholm, Denmark, March 15, 2022 – ExpreS2ion Biotech Holding AB’s affiliate ExpreS2ion Biotechnologies ApS (“ExpreS2ion") announces that a filmed company presentation by CEO Bent U. Frandsen at the Aktiespararna Aktiedagen investor event on March 14, 2022 is now available on the company’s website.The presentation provides an update on ExpreS[2]ion’s powerful platform for vaccine development, updates on the pipeline and progress towards key catalysts. The presentation can be found on the Company’s investor website via the following link: https://investor.expres2ionbio.com/presentations/

Fooditive Sweetener: The Sweet Idea that Sparked a Plant-based Revolution, into a Novel Food Application in 2022

Rotterdam, the Netherlands, March 15, 2022 | Fooditive, a pioneer in developing plant-based ingredients, is gearing up for a game-changer in the industry: a Novel Food licence from the European Food Safety Authority (EFSA) for its sweetener. The Dutch company has developed from a concept to a company worth of 26 million euros in 2022 and is making significant progress. Founded on the belief that sustainability is more than a trend, Fooditive provides innovative and natural ingredients to food and beverage manufacturers.The company's unique process allows them to develop a remarkable

Pihlajalinna Plc’s disposal of own shares based on the share-based incentive programme

Pihlajalinna Plc                   Stock Exchange Release     15 March 2022 at 3.20 p.m. Pihlajalinna Plc’s disposal of own shares based on the share-based incentive programme A total of 8,867 treasury shares of Pihlajalinna Plc has been conveyed on 15 March 2022 without consideration to the key persons of the company based on the performance-based earning period 2021 of the share-based incentive programme according to the terms and conditions of the plan. The decision of the Board of Directors is based on a share issue authorization granted by the Annual General Meeting of

New product names for selected Kiilto grouts and silicones

Changes to the brand names and packaging of selected Kiilto grouts and silicones start rolling out in March 2022. They are part of a comprehensive revamp of Kiilto Pro product packaging look, which is being carried out for each product group in phases. The changes have no other impact on the products or their characteristics.The changes affect the following products: Kiilto Saumalaasti has been renamed as Kiilto Pro Tile Grout. Kiilto Lattiasaumalaasti has been renamed as Kiilto Pro Floor Tile Grout. The names of two silicones are also being changed: Kiilto

Cyclyx welcomes freight railway BNSF to consortium and John Lovenburg to its executive advisory board

PORTSMOUTH, New Hampshire, USA, March 15, 2022 – Cyclyx International , a consortium-based supply chain innovation company with a mission to increase the recycling rate of plastic from 10% to 90%, has announced BNSF Railway  (BNSF), one of North America’s leading freight transportation companies, has joined the consortium and John Lovenburg, vice president of environment and sustainability at BNSF, will be joining Cyclyx’s executive advisory board (EAB). As Cyclyx begins to scale its ability to divert more waste plastic from the landfill and into

Visma to offer automatic invoice processing for accountants in the Benelux

Visma has acquired Dutch software company Lyanthe, offering accountancy firms in Belgium and the Netherlands a solution for automated accounting processes. With this acquisition, Visma now offers a complete automated processing street - from invoice to bookkeeping - for the accountancy sector in the Benelux. Lyanthe is being added to the Visma Connected Experience for accountants, a complete ecosystem supporting all activities within an accountancy firm. The software solutions are integrated, allowing them to share their data. This reduces processing time and minimises the risk of errors

Brighter signs a Memorandum of Understanding with Emirates Health Services in the UAE

Brighter AB (Publ.) (The Company) today announced that the company has signed a Memorandum of Understanding (MOU) with Emirates Health Services (EHS) in the United Arab Emirates (UAE) with the intention to jointly roll out an Actiste® user experience study.  The user experience study is expected to involve up to one hundred clinically diagnosed type 2 diabetes patients in the area and the patients will use the Actiste® Diabetes Management as a Service (ADMS) for a period of 90 days.  The primary aim of the user study is to confirm the positive user experience of patients and their

Ideagen’s Qualtrax selected by US accreditation body, AAVLD Accreditation Committee

The American Association of Veterinary Laboratory Diagnosticians (AAVLD) Accreditation Program is set to implement Ideagen Plc’s quality management software, Qualtrax, to support its mission to foster continuous improvement of veterinary diagnostic laboratories through accreditation.The AAVLD Accreditation Program is managed by a committee of veterinary laboratory professionals representing all regions in the US and Canada and collectively have expertise in a broad range of laboratory disciplines.  The AAVLD Accreditation Committee is an accreditation body serving publicly funded veterinary

PROJECT HAVELSTOFF SECURES THE SALE OF 4’000 TONS OF GREEN HYDROGEN PER YEAR, VIA LETTER OF INTENT SIGNED BY PLAGAZI AB (PUBL) AND WIRTZ ENERGIE + MINERALÖL GMBH.

Plagazi AB (publ) (“Plagazi” or the “Company”) has signed a letter of intent (“LOI”) together with WIRTZ Energie + Mineralöl GmbH (“Wirtz”) with the intent to form a long-term offtake agreement of 4’000 tons of green hydrogen, and potentially for e-fuels, produced in Plagazi’s German flagship project “Havelstoff” located in Brandenburg and run together with Neue Energien Premnitz. The estimated amount of hydrogen that Wirtz will source, covers the yearly production of one Plagazi HE-2000 unit and the parties have agreed upon a market competitive price per kilogram of H2.Wirtz is a regional

Redsense Medical and partners winner in standard setting procurement contract in Sweden

Redsense Medical, dialysis machine manufacturer Physidia, and distributor Nordic Medcom make up the winners of a public procurement contract in Sweden. The tender sets a new safety standard including a requirement to stop the blood flow if a blood leak is detected.Redsense is represented in the Scandinavian markets by Nordic Medcom, who also distributes the French home dialysis machine Physidia. Nordic Medcom submitted the winning bid with a complete system for hemodialysis consisting of a dialysis machine from Physidia and an alarm system from Redsense. If the Redsense alarm system detects

There are no items matching the current filter
There are no more items matching the current filter
Back to top